
India's drug controller has been issuing licenses to molecular diagnostic companies to just get their Covid-19 testing kits validated by the National Institute of Virology. A license to get a test validated is different from a license to manufacture a kit.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dlyRCy
via
IFTTT
0 comments:
Post a Comment